Lecithin and anionic lipids as an imitation of the lipid membrane in Parallel Artificial Membrane Permeation Assay (PAMPA) blood brain barrier Models

被引:2
作者
Otasevic, Svetlana [1 ]
Vojinovic, Tanja [1 ]
机构
[1] Univ Montenegro, Fac Med, Podgorica, Montenegro
来源
PROGRESS IN NUTRITION | 2020年 / 22卷 / 03期
关键词
Pampa; Blood-brain barrier; Lecithin; Anionic Lipids; DRUG; PERMEABILITY;
D O I
10.23751/pn.v22i3.9720
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background/Aim: One of the biggest challenges today is producing pharmaceutical forms of drugs for a successful treatment of pathological disorders of the central nervous system (CNS), bearing in mind that the brain tissue is highly selective when it comes to permeation of all substances, particularly drugs. In vitro Parallel Artificial Membrane Permeation Assay (PAMPA) drug permeability assay is an extremely important experimental model in the process of drug development. The aim of this study is to modify this model in order to test drug permeability through the blood-brain barrier. Methods: The substances with pharmacological activity tested in this study are the following: theophylline, sulfasalzine, risperidone, haloperidol, lidocaine and propranolol. We studied some of the key parameters which are important for good prediction of permeability - lipid composition and buffer composition. We also investigated the effect of co-solvents in the donor compartment and surfactants in the acceptor compartment, as well as the influence of the anionic lipid composition on drug permeability through the blood-brain barrier. As co-solvents, we used polyethylene glycol 200 (PEG 200) at concentrations of 1% and 0.24%, and as surfacants we applied sodim lauryl sulfate (SLS) at concentrations of 2% and 0.5%. In addition, the influence of lecithin and the anionic lipid composition was investigated and the following lipids were used for this purpose: 1,2-dioleoyl-sn-glycero-3-[phosphoL-serine] (PS18: 1), 1,2-dioleoyl-sn-glycero-3-phosphocholine (PC18: 1), and cholesterol. Results: The use of PEG 200 at concentrations of 1% and 0.24% proved to be good and allowed for a proper classification of the substances into those of high and low permeability. SLS at concentrations of 2 and 0.5% impaired the integrity of the lipid membrane, with the solution penetrating from the acceptor into the donor compartment. A brief experiment with methanol and SLS combined, showed that the membrane integrity remains preserved. The anionic lipid composition also proved favourable and the substances tested were properly classified into those of high and low permeability. Conclusion: The lipids that were used as an imitation of lipid membrane such as a 10% lecithin and combination of 1,2-dioleoyl-sn-glycero-3-[phospho-L-serine] (PS18: 1), 1,2-dioleoyl-sn-glycero-3-phosphocholine (PC18: 1) and cholesterol in the anionic-pampa model proved to be good and allowed for a proper classification of the substances into those of high and low permeability.
引用
收藏
页数:7
相关论文
共 16 条
  • [1] [Anonymous], 2012, Absorptionand Drug Development, DOI [DOI 10.1002/9781118286067.CH8, 10.1002/9781118286067.ch8]
  • [2] Drug permeability profiling using cell-free permeation tools: Overview and applications
    Berben, Philippe
    Bauer-Brandl, Annette
    Brandl, Martin
    Faller, Bernard
    Flaten, Goril Eide
    Jacobsen, Ann-Christin
    Brouwers, Joachim
    Augustijns, Patrick
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 119 : 219 - 233
  • [3] Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: A review
    Bicker, Joana
    Alves, Gilberto
    Fortuna, Ana
    Falcao, Amilcar
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2014, 87 (03) : 409 - 432
  • [4] A novel design of artificial membrane for improving the PAMPA model
    Chen, Xiaoxi
    Murawski, Anthony
    Patel, Karishma
    Crespi, Charles L.
    Balimane, Praveen V.
    [J]. PHARMACEUTICAL RESEARCH, 2008, 25 (07) : 1511 - 1520
  • [5] High throughput artificial membrane permeability assay for blood-brain barrier
    Di, L
    Kerns, EH
    Fan, K
    McConnell, OJ
    Carter, GT
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2003, 38 (03) : 223 - 232
  • [6] Physicochemical high throughput screening: Parallel artificial membrane permeation assay in the description of passive absorption processes
    Kansy, M
    Senner, F
    Gubernator, K
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (07) : 1007 - 1010
  • [7] The use of in vitro cell culture models for mechanistic studies and as permeability screens for the blood-brain barrier in the pharmaceutical industry - Background and current status in the drug discovery process
    Lundquist, S
    Renftel, M
    [J]. VASCULAR PHARMACOLOGY, 2002, 38 (06) : 355 - 364
  • [8] Prediction of drug transport through the blood-brain barrier in vivo:: A comparison between two in vitro cell models
    Lundquist, S
    Renftel, M
    Brillault, J
    Fenart, L
    Cecchelli, R
    Dehouck, MP
    [J]. PHARMACEUTICAL RESEARCH, 2002, 19 (07) : 976 - 981
  • [9] Quantifying the impact of transporters on cellular drug permeability
    Matsson, Par
    Fenu, Luca A.
    Lundquist, Patrik
    Wisniewski, Jacek R.
    Kansy, Manfred
    Artursson, Per
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2015, 36 (05) : 255 - 262
  • [10] In Vivo, In Vitro and In Silico Methods for Small Molecule Transfer Across the BBB
    Mensch, Jurgen
    Oyarzabal, Julen
    Mackie, Claire
    Augustijns, Patrick
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (12) : 4429 - 4468